Editorial comment on “Dutasteride, a 5 alpha‐reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia”

Ejemplares similares

• Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia
  por: So Inamura, et al.
  Publicado: (2024)
• Chronic inflammation in benign prostatic hyperplasia: Pathophysiology and treatment options
  por: So Inamura, et al.
  Publicado: (2024)
• Editorial Comment on “Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan”
  por: Takafumi Yagisawa, et al.
  Publicado: (2024)
• Quality of life and influencing factors in older adults with benign prostatic hyperplasia
  por: Chen‐ke Wang, et al.
  Publicado: (2024)
• Evaluation of learning curves for contact laser vaporization of the prostate using the 980 nm diode laser for benign prostatic hyperplasia
  por: Jun Furumido, et al.
  Publicado: (2024)